JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 1, 2004; DOI: 10.1124/jpet.104.066274


0022-3565/04/3102-459-468$20.00
JPET 310:459-468, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.066274v1
310/2/459    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abbruscato, T. J.
Right arrow Articles by Paulson, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abbruscato, T. J.
Right arrow Articles by Paulson, J. R.

NEUROPHARMACOLOGY

Regulation of Blood-Brain Barrier Na,K,2Cl-Cotransporter through Phosphorylation during in Vitro Stroke Conditions and Nicotine Exposure

Thomas J. Abbruscato, Steve P. Lopez, Karen Roder, and Jennifer R. Paulson

Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center School of Pharmacy, Amarillo, Texas

Nicotine, a major constituent of tobacco smoke, has important effects on brain recovery after focal ischemia (Wang et al., 1997). The purpose of this work is to systematically test the effects of nicotine during stroke conditions on blood-brain barrier (BBB) potassium transport, protein expression of the Na,K,2Cl-cotransporter (NKCC), and cell signaling pathways that control NKCC activity at the BBB. Confluent bovine brain microvessel endothelial cells (BBMECs) were exposed to both a hypoxic/aglycemic (H/A) environment to model BBB function during stroke conditions and nicotine and cotinine (N/C) to model plasma levels seen in smokers. BBMECs exhibit both Na,K-ATPase and NKCC activity (60 and 34 nmol/min/g, respectively) that contribute to 98% of the K+ uptake in cultured endothelial cells. An adaptive up-regulation of NKCC activity was identified to occur on the basolateral surface of the BBB after in vitro stroke conditions. Twenty-four hours of N/C exposure, at doses equivalent to plasma levels of smokers, combined with 6 h of H/A, reduced NKCC protein expression and total NKCC activity (shown by bumetanide-sensitive 86RB uptake) compared with 6 h of H/A alone (P < 0.01). Basolateral K+ transport was found to be modulated by nicotinic acetylcholine receptors expressed at the BBB. NKCC activity on the basolateral surface of the BBB is controlled by an ongoing phosphorylation/dephosphorylation processes. We have identified a potential mechanism in altered BBB response to stroke conditions with prior N/C exposure directly implicating damage to brain-to-blood K+ transport mediated at the BBB and perhaps neuronal recovery after stroke.


Received January 28, 2004; accepted April 1, 2004.

Address correspondence to: Dr. Thomas J. Abbruscato, Texas Tech University Heath Sciences Center, School of Pharmacy, 1300 Coulter, Amarillo, TX 79106. E-mail: tja{at}ama.ttuhsc.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Vemula, K. E. Roder, T. Yang, G. J. Bhat, T. J. Thekkumkara, and T. J. Abbruscato
A Functional Role for Sodium-Dependent Glucose Transport across the Blood-Brain Barrier during Oxygen Glucose Deprivation
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 487 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Jayakumar, M. Liu, M. Moriyama, R. Ramakrishnan, B. Forbush III, P. V. B. Reddy, and M. D. Norenberg
Na-K-Cl Cotransporter-1 in the Mechanism of Ammonia-induced Astrocyte Swelling
J. Biol. Chem., December 5, 2008; 283(49): 33874 - 33882.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. R. Paulson, K. E. Roder, G. McAfee, D. D. Allen, C. J. Van der Schyf, and T. J. Abbruscato
Tobacco Smoke Chemicals Attenuate Brain-to-Blood Potassium Transport Mediated by the Na,K,2Cl-Cotransporter during Hypoxia-Reoxygenation
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 248 - 254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Foroutan, J. Brillault, B. Forbush, and M. E. O'Donnell
Moderate-to-severe ischemic conditions increase activity and phosphorylation of the cerebral microvascular endothelial cell Na+-K+-Cl- cotransporter
Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1492 - C1501.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. R. Lockman, G. McAfee, W. J. Geldenhuys, C. J. Van der Schyf, T. J. Abbruscato, and D. D. Allen
Brain Uptake Kinetics of Nicotine and Cotinine after Chronic Nicotine Exposure
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 636 - 642.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. T. Hawkins, R. D. Egleton, and T. P. Davis
Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H212 - H219.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. T. Hawkins and T. P. Davis
The Blood-Brain Barrier/Neurovascular Unit in Health and Disease
Pharmacol. Rev., June 1, 2005; 57(2): 173 - 185.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.